Concepedia

Dawn D. Parker

DD

Statistics

Publications

31

Citations

1.2K

H-Index

21

Active since

1989

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (India)

Biocon (India)

Bristol-Myers Squibb (Germany)

Wellcome Trust

Dawn D. Parker is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacy, and pharmacology.

Publications per year

1989–2023

31

Publications

31

Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6

Vasker Bhattacherjee, L. E. Prescott, Ian Pike et al. · Journal of General Virology · 1995 · 138 citations

, , +17

Discovery and Preclinical Characterization of the Cyclopropylindolobenzazepine BMS-791325, A Potent Allosteric Inhibitor of the Hepatitis C Virus NS5B Polymerase

Robert G. Gentles, Min Ding, John A. Bender et al. · Journal of Medicinal Chemistry · 2014 · 100 citations · Full text

, , +17

Inhibitors of Human Immunodeficiency Virus Type 1 (HIV-1) Attachment. 5. An Evolution from Indole to Azaindoles Leading to the Discovery of 1-(4-Benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a Drug Candidate That Demonstrates Antiviral Activity in HIV-1-Infected Subjects

Tao Wang, Zhiwei Yin, Zhongxing Zhang et al. · Journal of Medicinal Chemistry · 2009 · 99 citations · Full text

, , +17

Hepatitis C Virus NS5A Replication Complex Inhibitors: The Discovery of Daclatasvir

Makonen Belema, Van N. Nguyen, Carol Bachand et al. · Journal of Medicinal Chemistry · 2014 · 87 citations · Full text

, , +17

Discovery of BMS-955176, a Second Generation HIV-1 Maturation Inhibitor with Broad Spectrum Antiviral Activity

Alicia Regueiro‐Ren, Zheng Liu, Yan Chen et al. · ACS Medicinal Chemistry Letters · 2016 · 54 citations

, , +16

1–5 of 31